novocure limited

novocure limited

NASDAQ:NVCR
NovoCure Limited

Chart

Detailed Quote

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States.

Featured Articles and Interviews
Press Releases

Novocure to Report Second Quarter 2026 Financial Results

Novocure's Optune Pax® Receives CE Mark for the Treatment of Locally Advanced Pancreatic Cancer

Novocure Announces Topline Data from the Phase 3 TRIDENT Trial Evaluating Earlier Use of Tumor Treating Fields Therapy in Newly Diagnosed Glioblastoma

The Conversation (0)